VYNE icon

VYNE Therapeutics
VYNE

Overview Fund Trends Analyst Outlook Journalist POV

49 hedge funds and large institutions have $579M invested in VYNE Therapeutics in 2018 Q1 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
49
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$151M
2
+$76.8M
3
+$60.1M
4
VP
venBio Partners
California
+$54.9M
5
NHAS
Novo Holdings A/S
Denmark
+$51.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$151M
2
$76.8M
3
$60.1M
4
$54.9M
5
$51.2M
6
$42M
7
$26.3M
8
$17.2M
9
$16M
10
$12.8M
11
$12.7M
12
$12.4M
13
$7.62M
14
$7.52M
15
$4.44M
16
$4.33M
17
$3.31M
18
$2.79M
19
$2.58M
20
$2.44M
21
$1.95M
22
$1.18M
23
$1.12M
24
$1.08M
25
$940K
1
2